Michael D. Ironside, Ph.D. has been named director of global project management at AMRI. In this newly created role, Dr. Ironside will be responsible for overseeing all project management activities related to products moving through AMRI’s pharmaceutical services organization. He will report to Dr. Steven Hagen, vice president of pharmaceutical development and manufacturing.

Dr. Ironside has more than 18 years of experience in the pharmaceutical industry. Most recently, he served in a consultant role as president of Rondaxe Scientific Solutions. Before joining Rondaxe, he was chief scientific officer at Biosignal, an emerging biotech company in Australia. Dr. Ironside also spent more than 8 years at AMRI, joining the company in 1998 as a section head in chemical development and subsequently assuming increased levels of responsibility culminating in the oversight and leadership of the chemical development and small scale cGMP unit.

Dr. Hagen remarked, “Dr. Ironside’s significant experience in project management and customer relations activities, in addition to his hands-on knowledge of the AMRI organization, make him an immediately value-added member of our organization. As we continue to grow in the area of manufacturing services, the ability to seamlessly manage projects across the pharmaceutical development spectrum adds value to our customers through enhancement of knowledge transfer, elevated level of quality and shorter time to deliver.”